Search course

Use the search function to find more information about the study programmes and courses available at Chalmers. When there is a course homepage, a house symbol is shown that leads to this page.

Graduate courses

Departments' graduate courses for PhD-students.

​​​​
​​

Syllabus for

Academic year
KMG046 - Drug development  
Utveckling av läkemedel
 
Syllabus adopted 2019-02-12 by Head of Programme (or corresponding)
Owner: MPBIO
7,5 Credits
Grading: TH - Five, Four, Three, Fail
Education cycle: Second-cycle
Major subject: Bioengineering
Department: 0114 - KEMI OCH MOLEKYLÄRBIOLOGI GU


Teaching language: English
Application code: 08129
Open for exchange students: Yes
Maximum participants: 30

Module   Credit distribution   Examination dates
Sp1 Sp2 Sp3 Sp4 Summer course No Sp
0114 Examination 7,5c Grading: TH   7,5c   Contact examiner,  Contact examiner,  Contact examiner

In programs

MPBIO BIOTECHNOLOGY, MSC PROGR, Year 2 (elective)
MPBIO BIOTECHNOLOGY, MSC PROGR, Year 1 (elective)

Examiner:

Margit Mahlapuu

  Go to Course Homepage

Replaces

KMG045   Drug development


Eligibility:


In order to be eligible for a second cycle course the applicant needs to fulfil the general and specific entry requirements of the programme that owns the course. (If the second cycle course is owned by a first cycle programme, second cycle entry requirements apply.)
Exemption from the eligibility requirement: Applicants enrolled in a programme at Chalmers where the course is included in the study programme are exempted from fulfilling these requirements.

Course specific prerequisites

Basic courses in cell and molecular biology.

Aim

The student should be oriented about concepts, working methods and strategies in modern drug development.

Learning outcomes (after completion of the course the student should be able to)

The student should be oriented about:

  • concepts, working methods and strategies in modern drug development, both with respect to small molecules and proteins as drugs.
The student should be able to:
  • Comprehend specific strengths and weaknesses of different genetic model organisms used in target discovery
  • Evaluate the significance of genetic differences between patients in individualised drug therapy
  • Interpret structural information about drug targets in the context of interactions with small molecules
  • Understand fundaments of small molecule screening models
  • Give accounts of the challenges met by drugs that have recently come to the market

Content

The course content consists of lectures, seminars, practical demonstrations and written examination. Invited speakers will treat different applied and fundamental aspects, and opportunities will be offered to study practical working methods.

The process of developing a new drug is described, with emphasis on the early part ("drug discovery").

The following items are treated: Identification and validation of new cellular target molecules, bioinformatics, genetic model organisms, and methods for high- throughput screening.

Organisation

The course content consists of lectures, seminars, practical demonstrations and written examination.

Literature

Scientific papers selected by the teachers

Examination including compulsory elements

Written, with two components: home essay and final exam.


Published: Wed 26 Feb 2020.